Self-administered COgnitive Personalized Training in Early Psychosis
Launched by CENTRE HOSPITALIER ST ANNE · Oct 8, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called SCOPe, is studying a new way to help young people who are experiencing their first episode of psychosis. The goal is to use a special online tool that allows participants to engage in personalized cognitive training, which focuses on improving thinking skills that may have been affected by psychosis. By starting this training early, researchers hope to enhance the quality of life and help with education and job opportunities for these young individuals. This approach is designed to be easy to access and use, so anyone can benefit from it, regardless of where they live.
To be eligible for the trial, participants need to be between 16 and 35 years old and recently diagnosed with psychosis. They must also be seeking help at one of the participating centers and able to provide written consent, with a guardian's consent if they are minors. Those interested can expect to use a user-friendly app to work on cognitive exercises tailored to their needs. It's important to note that individuals with severe health issues, significant reading difficulties, or those currently involved in other clinical trials will not be able to participate. Through this trial, researchers aim to understand how cognitive training can help young people recover better and improve their brain's ability to adapt and grow.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescent and young adults, both genders, aged 16 to 35,
- • Seeking help in one of the recruiting centers,
- • Newly diagnosed as experiencing an Episode of Psychosis (reaching criteria as described in the Comprehensive Assessment of at Risk Mental States (CAARMS) within the year
- • Written informed consent signed (and from one legal guardian for minors).
- Exclusion Criteria:
- • Severe and unstabilized medical conditions,
- • Insufficient level in reading and/or French language,
- • Absence of medical insurance,
- • Participation in another intervention trial,
- • Enforced hospitalization (ASPDT, ASPPI, ASPRE),
- • Intellectuel Deficiency (IQ\<70), and / or sensorimotor deficits incompatible with the cognitive training,
About Centre Hospitalier St Anne
Centre Hospitalier St. Anne is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a strong emphasis on mental health and neurology, the center is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. By fostering collaboration among multidisciplinary teams of experienced researchers and healthcare professionals, Centre Hospitalier St. Anne aims to contribute to the development of new therapies and treatment modalities, ultimately enhancing the quality of care for patients in both local and global contexts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Marie Odile MO KREBS, PROFESSEUR
Principal Investigator
GHU PARIS Saint-Anne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported